Navicare Biotech Co., Ltd. (TPEX:8472)
Taiwan · Delayed Price · Currency is TWD 74.20
-4.00 (-5.12%)
Sep 8, 2026, 1:30 PM CST
Navicare Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 67.91 | 159.19 | 79 | 86.31 | 115.42 | 136.32 |
Short-Term Investments | 96.75 | 67.26 | 9.7 | 40.26 | 59.55 | 442.54 |
Trading Asset Securities | 0.13 | 3.86 | 10.43 | 14.44 | 67.91 | 79.72 |
Cash & Short-Term Investments | 164.79 | 230.32 | 99.12 | 141.01 | 242.88 | 658.58 |
Cash Growth | -23.10% | 132.35% | -29.70% | -41.94% | -63.12% | -10.91% |
Accounts Receivable | 90.92 | 75.59 | 30.23 | 109.45 | 37.73 | 31.49 |
Other Receivables | 3.32 | 2.17 | 2.44 | 11.52 | 1.8 | 1.52 |
Receivables | 94.24 | 77.77 | 32.67 | 120.96 | 39.53 | 33.01 |
Inventory | 33.32 | 36.55 | 50.44 | 26.12 | 18.28 | 0.02 |
Prepaid Expenses | 24.15 | 25.34 | 49.99 | 93.44 | 143.9 | 109.18 |
Other Current Assets | 1.74 | 0.38 | 0.79 | 0.28 | 0.07 | 0.03 |
Total Current Assets | 318.23 | 370.35 | 233.01 | 381.81 | 444.65 | 800.81 |
Property, Plant & Equipment | 274.37 | 280.75 | 296.27 | 272.88 | 243.89 | 16.97 |
Other Intangible Assets | 4.41 | 4.93 | 5.24 | 5.92 | 6.07 | 5.5 |
Long-Term Deferred Tax Assets | 45.78 | 40.69 | 43.99 | 46.47 | 27.17 | 16.15 |
Other Long-Term Assets | 351.41 | 352.9 | 421.03 | 475.34 | 489.96 | 209.32 |
Total Assets | 994.2 | 1,050 | 999.54 | 1,182 | 1,212 | 1,049 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 197.73 | 247.82 | 235.91 | 311.28 | 296.15 | 232.62 |
Accrued Expenses | 9.78 | 13.67 | 15.73 | 22.19 | 20.33 | 20.89 |
Short-Term Debt | 85 | 90 | 100 | 80 | 60 | - |
Current Portion of Long-Term Debt | 11.09 | 10.97 | 10.74 | 6.66 | 3.9 | - |
Current Portion of Leases | 2.85 | 2.35 | 5.02 | 7.25 | 7.45 | 7.28 |
Current Income Taxes Payable | 7.28 | 1.34 | - | 2.81 | - | 4.38 |
Current Unearned Revenue | 101.01 | 94.61 | 102.85 | 112.9 | 124.22 | 135.94 |
Other Current Liabilities | 84.22 | 84.5 | 87.39 | 106.27 | 109.03 | 101.42 |
Total Current Liabilities | 498.95 | 545.26 | 557.64 | 649.35 | 621.09 | 502.53 |
Long-Term Debt | 219.06 | 223.25 | 140.82 | 151.57 | 158.17 | - |
Long-Term Leases | 0.39 | 0.9 | 4.21 | 3.36 | 2.69 | 5.98 |
Long-Term Deferred Tax Liabilities | 15.9 | 8.67 | 10.8 | 13.21 | 13.32 | 12.97 |
Other Long-Term Liabilities | 1.04 | 1.04 | 1 | 1.4 | 1.1 | 0 |
Total Liabilities | 735.35 | 779.12 | 714.47 | 818.89 | 796.38 | 521.48 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 177.36 | 177.36 | 177.36 | 177.36 | 177.36 | 177.36 |
Additional Paid-In Capital | 92.87 | 116.14 | 186.17 | 238 | 264.17 | 280.81 |
Retained Earnings | -11.67 | -23.27 | -78.46 | -51.83 | -26.17 | 66.26 |
Comprehensive Income & Other | 0.29 | 0.27 | - | - | - | - |
Total Common Equity | 258.85 | 270.5 | 285.07 | 363.53 | 415.36 | 524.43 |
Minority Interest | - | - | - | - | - | 2.84 |
Shareholders' Equity | 258.85 | 270.5 | 285.07 | 363.53 | 415.36 | 527.27 |
Total Liabilities & Equity | 994.2 | 1,050 | 999.54 | 1,182 | 1,212 | 1,049 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 318.38 | 327.47 | 260.79 | 248.83 | 232.22 | 13.26 |
Net Cash (Debt) | -153.6 | -97.15 | -161.67 | -107.83 | 10.66 | 645.32 |
Net Cash Growth | - | - | - | - | -98.35% | -11.01% |
Net Cash Per Share | -8.66 | -5.48 | -9.12 | -6.08 | 0.60 | 36.33 |
Filing Date Shares Outstanding | 17.74 | 17.74 | 17.74 | 17.74 | 17.74 | 17.74 |
Total Common Shares Outstanding | 17.74 | 17.74 | 17.74 | 17.74 | 17.74 | 17.74 |
Working Capital | -180.72 | -174.91 | -324.63 | -267.53 | -176.43 | 298.28 |
Book Value Per Share | 14.59 | 15.25 | 16.07 | 20.50 | 23.42 | 29.57 |
Tangible Book Value | 254.44 | 265.56 | 279.83 | 357.62 | 409.29 | 518.93 |
Tangible Book Value Per Share | 14.35 | 14.97 | 15.78 | 20.16 | 23.08 | 29.26 |
Land | 183.01 | 183.01 | 183.01 | 163.82 | 163.82 | - |
Buildings | 73.87 | 73.87 | 73.87 | 66.62 | 66.62 | - |
Machinery | 43.95 | 43.95 | 43.84 | 38.95 | 13.56 | 11.02 |
Leasehold Improvements | 13.42 | 13.42 | 13.42 | 10.67 | - | - |